Home > Publications database > Genetically Determined Height and Risk of Non-hodgkin Lymphoma. > print

001     153956
005     20240229123054.0
024 7 _ |a 10.3389/fonc.2019.01539
|2 doi
024 7 _ |a pmid:32064237
|2 pmid
024 7 _ |a pmc:PMC6999122
|2 pmc
024 7 _ |a altmetric:74633153
|2 altmetric
037 _ _ |a DKFZ-2020-00546
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Moore, Amy
|b 0
245 _ _ |a Genetically Determined Height and Risk of Non-hodgkin Lymphoma.
260 _ _ |a Lausanne
|c 2020
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1584016871_23459
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Although the evidence is not consistent, epidemiologic studies have suggested that taller adult height may be associated with an increased risk of some non-Hodgkin lymphoma (NHL) subtypes. Height is largely determined by genetic factors, but how these genetic factors may contribute to NHL risk is unknown. We investigated the relationship between genetic determinants of height and NHL risk using data from eight genome-wide association studies (GWAS) comprising 10,629 NHL cases, including 3,857 diffuse large B-cell lymphoma (DLBCL), 2,847 follicular lymphoma (FL), 3,100 chronic lymphocytic leukemia (CLL), and 825 marginal zone lymphoma (MZL) cases, and 9,505 controls of European ancestry. We evaluated genetically predicted height by constructing polygenic risk scores using 833 height-associated SNPs. We used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for association between genetically determined height and the risk of four NHL subtypes in each GWAS and then used fixed-effect meta-analysis to combine subtype results across studies. We found suggestive evidence between taller genetically determined height and increased CLL risk (OR = 1.08, 95% CI = 1.00-1.17, p = 0.049), which was slightly stronger among women (OR = 1.15, 95% CI: 1.01-1.31, p = 0.036). No significant associations were observed with DLBCL, FL, or MZL. Our findings suggest that there may be some shared genetic factors between CLL and height, but other endogenous or environmental factors may underlie reported epidemiologic height associations with other subtypes.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Kane, Eleanor
|b 1
700 1 _ |a Wang, Zhaoming
|b 2
700 1 _ |a Panagiotou, Orestis A
|b 3
700 1 _ |a Teras, Lauren R
|b 4
700 1 _ |a Monnereau, Alain
|b 5
700 1 _ |a Wong Doo, Nicole
|b 6
700 1 _ |a Machiela, Mitchell J
|b 7
700 1 _ |a Skibola, Christine F
|b 8
700 1 _ |a Slager, Susan L
|b 9
700 1 _ |a Salles, Gilles
|b 10
700 1 _ |a Camp, Nicola J
|b 11
700 1 _ |a Bracci, Paige M
|b 12
700 1 _ |a Nieters, Alexandra
|b 13
700 1 _ |a Vermeulen, Roel C H
|b 14
700 1 _ |a Vijai, Joseph
|b 15
700 1 _ |a Smedby, Karin E
|b 16
700 1 _ |a Zhang, Yawei
|b 17
700 1 _ |a Vajdic, Claire M
|b 18
700 1 _ |a Cozen, Wendy
|b 19
700 1 _ |a Spinelli, John J
|b 20
700 1 _ |a Hjalgrim, Henrik
|b 21
700 1 _ |a Giles, Graham G
|b 22
700 1 _ |a Link, Brian K
|b 23
700 1 _ |a Clavel, Jacqueline
|b 24
700 1 _ |a Arslan, Alan A
|b 25
700 1 _ |a Purdue, Mark P
|b 26
700 1 _ |a Tinker, Lesley F
|b 27
700 1 _ |a Albanes, Demetrius
|b 28
700 1 _ |a Ferri, Giovanni M
|b 29
700 1 _ |a Habermann, Thomas M
|b 30
700 1 _ |a Adami, Hans-Olov
|b 31
700 1 _ |a Becker, Nikolaus
|0 P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab
|b 32
|u dkfz
700 1 _ |a Benavente, Yolanda
|b 33
700 1 _ |a Bisanzi, Simonetta
|b 34
700 1 _ |a Boffetta, Paolo
|b 35
700 1 _ |a Brennan, Paul
|b 36
700 1 _ |a Brooks-Wilson, Angela R
|b 37
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 38
|u dkfz
700 1 _ |a Conde, Lucia
|b 39
700 1 _ |a Cox, David G
|b 40
700 1 _ |a Curtin, Karen
|b 41
700 1 _ |a Foretova, Lenka
|b 42
700 1 _ |a Gapstur, Susan M
|b 43
700 1 _ |a Ghesquières, Hervé
|b 44
700 1 _ |a Glenn, Martha
|b 45
700 1 _ |a Glimelius, Bengt
|b 46
700 1 _ |a Jackson, Rebecca D
|b 47
700 1 _ |a Lan, Qing
|b 48
700 1 _ |a Liebow, Mark
|b 49
700 1 _ |a Maynadie, Marc
|b 50
700 1 _ |a McKay, James
|b 51
700 1 _ |a Melbye, Mads
|b 52
700 1 _ |a Miligi, Lucia
|b 53
700 1 _ |a Milne, Roger L
|b 54
700 1 _ |a Molina, Thierry J
|b 55
700 1 _ |a Morton, Lindsay M
|b 56
700 1 _ |a North, Kari E
|b 57
700 1 _ |a Offit, Kenneth
|b 58
700 1 _ |a Padoan, Marina
|b 59
700 1 _ |a Patel, Alpa V
|b 60
700 1 _ |a Piro, Sara
|b 61
700 1 _ |a Ravichandran, Vignesh
|b 62
700 1 _ |a Riboli, Elio
|b 63
700 1 _ |a de Sanjose, Silvia
|b 64
700 1 _ |a Severson, Richard K
|b 65
700 1 _ |a Southey, Melissa C
|b 66
700 1 _ |a Staines, Anthony
|b 67
700 1 _ |a Stewart, Carolyn
|b 68
700 1 _ |a Travis, Ruth C
|b 69
700 1 _ |a Weiderpass, Elisabete
|b 70
700 1 _ |a Weinstein, Stephanie
|b 71
700 1 _ |a Zheng, Tongzhang
|b 72
700 1 _ |a Chanock, Stephen J
|b 73
700 1 _ |a Chatterjee, Nilanjan
|b 74
700 1 _ |a Rothman, Nathaniel
|b 75
700 1 _ |a Birmann, Brenda M
|b 76
700 1 _ |a Cerhan, James R
|b 77
700 1 _ |a Berndt, Sonja I
|b 78
773 _ _ |a 10.3389/fonc.2019.01539
|g Vol. 9, p. 1539
|0 PERI:(DE-600)2649216-7
|p 1539
|t Frontiers in oncology
|v 9
|y 2020
|x 2234-943X
909 C O |o oai:inrepo02.dkfz.de:153956
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT ONCOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21